RNA Avidity Biosciences, Inc. - Common Stock
$13,16
Prix · Aoû 19, 2026
Données fondamentales au Fév 23, 2026
Fourchette 52 semaines
$11–$73
3% of range
Note des analystes
BUY
7 analysts
Objectif de cours
$25
+90% upside
P/E (TTM)
-2.6
ROE
-47.5%
Marge nette
-3650.4%
RNA Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$13.16
Capitalisation Boursière
$1.99B
P/E (TTM)
-2.6
BPA (TTM)
$-4.97
Revenus (TTM)
$19M
Rendement div.
—
ROE
-47.5%
Dette/Capitaux propres
—
Fourchette 52 semaines
$11 – $73
RNA Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$19M
2018-12-31
→
2025-12-31
BPA
$-4.97
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$-664M
2020-12-31
→
2025-12-31
Marges
-3650.4%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
RNA
Médiane des pairs
P/E (TTM)
-2.6
—
P/S (TTM)
106.1
9.5
P/B
1.2
1.1
Price / FCF (Cours / FCF)
-3.0
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
RNA
Médiane des pairs
Operating Margin (Marge d'exploitation)
-3977.3%
—
Net Profit Margin (Marge nette)
-3650.4%
-348.2%
ROA
-38.9%
-40.7%
ROE
-47.5%
-49.8%
ROIC
-44.2%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
RNA
Médiane des pairs
Current Ratio (Ratio de liquidité)
9.2
12.1
Quick Ratio (Ratio de liquidité réduite)
2.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
RNA
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
72.1%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
26.7%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
22.5%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
RNA
Médiane des pairs
RNA Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
7 analystes
- Achat fort 2 28,6%
- Achat 4 57,1%
- Conserver 1 14,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
4 analystes · 2026-08-19
Bas
$25.00
Haut
$25.00
Objectif médian
$25.00
+90,0%
Objectif moyen
$25.00
+90,0%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.09%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.97 | $-1.06 | 0.09% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| CNXU | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| NBP | — | — | — | — | — | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $11M | $10M | $9M | $9M | $7M | $2M | |
| R&D Expense | $559M | $304M | $191M | $150M | $101M | $38M | $15M | |
| SG&A Expense | $206M | $86M | $54M | $38M | $26M | $13M | $5M | |
| Operating Expenses | $765M | $390M | $245M | $188M | $127M | $51M | $20M | |
| Operating Income | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | $-17M | |
| Interest Expense | · | · | · | $0 | $0 | $209.0K | $7M | |
| Other Non-op | $-2M | $-248.0K | $-594.0K | $-57.0K | $-62.0K | $-75.0K | $0 | |
| Pretax Income | $-685M | $-322M | $-212M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | $-25M | |
| EPS (Basic) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| EPS (Diluted) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| Shares (Basic) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| Shares (Diluted) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| EBITDA | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | · |
Bilan 24
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $220M | $185M | $340M | $320M | $321M | $95M | |
| Short-term Investments | · | · | · | · | $85M | $7M | · | |
| Receivables | · | $0 | $1M | $2M | · | · | · | |
| Prepaid Expense | $102M | $41M | $16M | $12M | $6M | · | · | |
| Other Current Assets | $53M | $19M | · | $2M | · | · | · | |
| Current Assets | $1.80B | $1.54B | $611M | $623M | $411M | $332M | $96M | |
| PP&E (Net) | $23M | $13M | $8M | $6M | $5M | $1M | $631.0K | |
| PP&E (Gross) | $35M | $21M | $14M | $9M | $7M | $3M | $2M | |
| Accum. Depreciation | $12M | $8M | $5M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $82M | $521.0K | $301.0K | $598.0K | $599.0K | $47.0K | $600.0K | |
| Total Assets | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Accounts Payable | $12M | $8M | $9M | $5M | $3M | $8M | $2M | |
| Current Liabilities | $195M | $98M | $81M | $52M | $30M | $15M | $10M | |
| Capital Leases | $45M | $3M | $6M | $8M | $10M | $938.0K | $393.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $45.0K | |
| Total Liabilities | $269M | $139M | $128M | $61M | $46M | $28M | $28M | |
| Long-term Debt | · | · | · | · | · | · | $5M | |
| Common Stock | $15.0K | $12.0K | $8.0K | $7.0K | $5.0K | $4.0K | $0 | |
| Paid-in Capital | · | · | · | $939M | $566M | $373M | $-43M | |
| Retained Earnings | $-1.58B | $-893M | $-571M | $-359M | $-185M | $-67M | $-22M | |
| AOCI | $3M | $3M | $125.0K | $-3M | $-187.0K | $-5.0K | · | |
| Stockholders' Equity | $1.69B | $1.42B | $501M | $578M | $381M | $306M | $-65M | |
| Liabilities + Equity | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Shares Outstanding | 151,205,000 | 119,893,000 | 79,275,000 | 69,768,000 | 47,754,000 | 37,569,000 | 2,989,000 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $98M | $51M | $38M | $27M | $17M | $4M | $406.0K | |
| Operating Cash Flow | $-650M | $-301M | $-119M | $-136M | $-95M | $-37M | $2M | |
| CapEx | $13M | $7M | $4M | $3M | $4M | $1M | $235.0K | |
| Investing Cash Flow | $-38M | $-854M | $-130M | $-190M | $-83M | $-8M | $-235.0K | |
| Net Debt Issued | · | · | · | $0 | $0 | $-5M | · | |
| Stock Issued | $837M | $762M | $61M | $345M | $175M | $274M | · | |
| Net Stock Activity | $837M | $762M | $61M | $345M | $20M | · | · | |
| Financing Cash Flow | $851M | $1.19B | $94M | $346M | $176M | $272M | $89M | |
| Net Change in Cash | $163M | $37M | $-155M | $20M | $-1M | $227M | $91M | |
| Free Cash Flow | $-664M | $-308M | $-123M | $-139M | $-99M | $-38M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| Net Margin | -3650.4% | -2957.7% | -2219.9% | -1886.3% | -1265.4% | -653.5% | · | |
| Pretax Margin | -3650.4% | · | · | · | · | · | · | |
| EBITDA Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| ROA | -38.9% | -29.4% | -33.5% | -32.6% | -31.0% | -20.6% | · | |
| ROE | -47.5% | -22.0% | -41.7% | -36.4% | -30.4% | -14.2% | · | |
| ROIC | -44.2% | · | · | · | · | · | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 | 22.7 | · | |
| Quick Ratio | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 | 22.5 | · | |
| Interest Coverage | · | · | · | · | · | -211.9 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | 19.7 | 5.5 | · | · | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 72.1% | 14.0% | 3.6% | -1.1% | 37.4% | · | · | |
| Revenue CAGR 3Y | 26.7% | 5.3% | 12.1% | · | · | · | · | |
| Revenue CAGR 5Y | 22.5% | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $11M | $10M | $9M | $9M | $7M | · | |
| Net Income TTM | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | · | |
| Market Cap | $10.91B | $3.49B | $717M | $1.55B | $1.14B | $959M | · | |
| P/E | -14.5 | -10.1 | -3.1 | -6.6 | -8.3 | -12.4 | · | |
| P/S | 581.5 | 319.9 | 75.0 | 167.8 | 121.7 | 141.3 | · | |
| P/B | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Tangible Book | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Cash Flow | -16.8 | -11.6 | -6.0 | -11.4 | -12.0 | -25.8 | · | |
| P / FCF | -16.4 | -11.3 | -5.8 | -11.1 | -11.5 | -25.1 | · | |
| Earnings Yield | -6.9% | -9.9% | -32.1% | -15.0% | -12.0% | -8.0% | · |
Compte de résultat 12
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $860.0K | $12M | $4M | $2M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | |
| R&D Expense | $167M | $155M | $138M | $99M | $96M | $77M | $64M | $67M | $53M | $48M | $43M | $48M | $46M | $37M | $40M | $28M | |
| SG&A Expense | $89M | $46M | $37M | $34M | $28M | $23M | $21M | $14M | $16M | $14M | $12M | $12M | $10M | $10M | $9M | $9M | |
| Operating Expenses | $255M | $201M | $175M | $133M | $124M | $100M | $85M | $81M | $69M | $61M | $55M | $60M | $56M | $47M | $48M | $36M | |
| Operating Income | $-254M | $-189M | $-171M | $-132M | $-121M | $-98M | $-83M | $-77M | $-67M | $-59M | $-53M | $-58M | $-53M | $-45M | $-46M | $-34M | |
| Other Non-op | $-477.0K | $-380.0K | $-651.0K | $-435.0K | $201.0K | $-232.0K | $-116.0K | $-101.0K | $-105.0K | $-13.0K | $-162.0K | $-314.0K | $-18.0K | $-12.0K | $-2.0K | $-25.0K | |
| Net Income | $-237M | $-174M | $-157M | $-116M | $-102M | $-80M | $-71M | $-69M | $-60M | $-52M | $-47M | $-52M | $-50M | $-44M | $-46M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| EPS (Diluted) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| Shares (Basic) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| Shares (Diluted) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| EBITDA | · | $-189M | $-171M | $-132M | · | $-98M | $-83M | $-77M | · | $-59M | $-53M | $-58M | · | $-45M | · | $-34M |
Bilan 21
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $350M | $244M | $254M | $220M | $370M | $576M | $471M | · | $86M | $154M | $119M | · | $144M | $125M | $139M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $262M | $273M | $258M | |
| Receivables | · | · | · | · | · | $0 | $0 | $2M | · | · | $1M | · | · | · | · | · | |
| Prepaid Expense | $102M | $90M | $67M | $55M | $41M | $33M | $30M | $19M | · | · | $11M | · | · | · | · | · | |
| Other Current Assets | $53M | $60M | $43M | · | $19M | · | · | · | · | · | $6M | · | · | · | · | · | |
| Current Assets | $1.80B | $1.97B | $1.25B | $1.43B | $1.54B | $1.62B | $1.33B | $934M | · | $555M | $595M | $597M | · | $414M | $404M | $405M | |
| PP&E (Net) | $23M | $22M | $21M | $16M | $13M | $9M | $8M | $9M | · | $8M | $8M | $8M | · | $6M | $6M | $5M | |
| PP&E (Gross) | $35M | $32M | $30M | $24M | $21M | $17M | $15M | $15M | · | $13M | $12M | $11M | · | $9M | $9M | $7M | |
| Accum. Depreciation | $12M | $10M | $10M | $9M | $8M | $7M | $7M | $6M | · | $5M | $4M | $4M | · | $3M | $2M | $2M | |
| Other Non-current Assets | $82M | $91M | $91M | $739.0K | $521.0K | $318.0K | $364.0K | $425.0K | · | $344.0K | $424.0K | $474.0K | · | $523.0K | $415.0K | $548.0K | |
| Total Assets | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Accounts Payable | $12M | $10M | $4M | $7M | $8M | $8M | $9M | $2M | · | $6M | $6M | $4M | · | $26M | $21M | $19M | |
| Current Liabilities | $195M | $170M | $135M | $85M | $98M | $91M | $84M | $75M | · | $49M | $45M | $48M | · | $43M | $34M | $31M | |
| Capital Leases | $45M | $46M | $1M | $2M | $3M | $4M | $5M | $5M | · | $7M | $6M | $7M | · | $8M | $9M | $9M | |
| Total Liabilities | $269M | $248M | $176M | $130M | $139M | $137M | $126M | $121M | · | $56M | $52M | $55M | · | $54M | $46M | $45M | |
| Common Stock | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $10.0K | · | $7.0K | $7.0K | $7.0K | · | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-1.58B | $-1.34B | $-1.17B | $-1.01B | $-893M | $-791M | $-710M | $-640M | · | $-510M | $-458M | $-411M | · | $-308M | $-264M | $-219M | |
| AOCI | $3M | $2M | $2M | $3M | $3M | $7M | $-453.0K | $-464.0K | · | $-2M | $-3M | $-2M | · | $-3M | $-3M | $-2M | |
| Stockholders' Equity | $1.69B | $1.89B | $1.19B | $1.33B | $1.42B | $1.50B | $1.22B | $831M | $501M | $517M | $559M | $559M | $578M | $377M | $374M | $376M | |
| Liabilities + Equity | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Shares Outstanding | 151,205,000 | 146,771,000 | 120,778,000 | 120,512,000 | 119,893,000 | 118,900,000 | 109,266,000 | 95,594,000 | 79,275,000 | 74,101,000 | 74,070,000 | 70,813,000 | 69,768,000 | 54,446,000 | 52,081,000 | 49,281,000 |
Flux de trésorerie 9
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $43M | $19M | $18M | $18M | $14M | $14M | $13M | $10M | $10M | $10M | $9M | $9M | $7M | $7M | $7M | $6M | |
| Operating Cash Flow | $-170M | $-156M | $-200M | $-125M | $-100M | $-66M | $-65M | $-70M | $17M | $-37M | $-50M | $-49M | $-39M | $-32M | $-36M | $-30M | |
| CapEx | $6M | $712.0K | $3M | $4M | $4M | $2M | $531.0K | $915.0K | $863.0K | $923.0K | $622.0K | $2M | $850.0K | $-107.0K | $1M | $758.0K | |
| Investing Cash Flow | $207M | $-588M | $185M | $157M | $-64M | $-482M | $-275M | $-33M | $51M | $-31M | $46M | $-196M | $-8M | $11M | $-18M | $-175M | |
| Stock Issued | $-538.0K | $837M | $0 | $0 | $-500.0K | $324M | $433M | $6M | $0 | $0 | $38M | $22M | $243M | $39M | $38M | $24M | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $6M | · | · | · | $22M | · | · | · | $24M | |
| Financing Cash Flow | $-5M | $850M | $4M | $2M | $14M | $342M | $447M | $389M | $32M | $40.0K | $39M | $23M | $244M | $40M | $39M | $24M | |
| Net Change in Cash | $32M | $106M | $-10M | $34M | $-150M | $-206M | $107M | $286M | $99M | $-68M | $35M | $-222M | $197M | $19M | $-14M | $-181M | |
| Free Cash Flow | · | · | · | $-129M | · | · | · | $-71M | · | · | · | $-51M | · | · | · | $-30M |
Rentabilité 5
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| Net Margin | · | -1398.3% | -4089.3% | -7360.0% | · | -3441.7% | -3461.8% | -1943.4% | · | -1858.0% | -2030.4% | -2346.3% | · | -1756.6% | · | -1907.2% | |
| EBITDA Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| ROA | · | -9.2% | -11.6% | -9.6% | · | -7.3% | -7.2% | -8.8% | · | -10.4% | -9.1% | -10.1% | · | -10.2% | · | -9.3% | |
| ROE | · | -10.3% | -13.0% | -10.7% | · | -8.0% | -8.0% | -9.9% | · | -11.7% | -10.1% | -11.2% | · | -11.3% | · | -10.3% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.6 | 9.3 | 16.9 | · | 17.8 | 15.8 | 12.5 | · | 11.4 | 13.1 | 12.4 | · | 9.7 | · | 13.1 | |
| Quick Ratio | · | 2.1 | 1.8 | 3.0 | · | 4.1 | 6.8 | 6.3 | · | 1.8 | 3.4 | 2.5 | · | 9.5 | · | 12.8 |
Efficacité 2
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 3.5 | 4.5 | · | · | 3.9 | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $20M | $10M | $9M | · | $11M | $11M | $11M | · | $10M | $9M | $9M | · | $9M | · | $9M | |
| Net Income TTM | · | $-528M | $-424M | $-336M | · | $-272M | $-239M | $-221M | · | $-195M | $-189M | $-176M | · | $-153M | · | $-114M | |
| Market Cap | · | $6.39B | $3.43B | $3.56B | · | $5.46B | $4.46B | $2.44B | · | $473M | $821M | $1.09B | · | $889M | · | $910M | |
| P/E | · | -10.8 | -8.3 | -9.9 | · | -16.4 | -14.5 | -8.8 | · | -2.2 | -3.5 | -4.8 | · | -5.2 | · | · | |
| P/S | · | 316.1 | 350.0 | 374.6 | · | 508.4 | 416.3 | 223.6 | · | 48.0 | 89.2 | 125.1 | · | 103.2 | · | 98.2 | |
| P/B | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Tangible Book | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Cash Flow | · | · | · | -28.5 | · | · | · | -34.7 | · | · | · | -22.2 | · | · | · | -30.8 | |
| P / FCF | · | · | · | -27.7 | · | · | · | -34.2 | · | · | · | -21.4 | · | · | · | -30.0 | |
| Earnings Yield | · | -9.2% | -12.0% | -10.1% | · | -6.1% | -6.9% | -11.4% | · | -45.9% | -28.3% | -20.8% | · | -19.2% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $19M | $11M | $10M | $9M | $9M |
| Marge d'exploitation % | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% |
| Résultat net | $-685M | $-322M | $-212M | $-174M | $-118M |
| BPA dilué | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 |
| Ratio de liquidité réduite | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-664M | $-308M | $-123M | $-139M | $-99M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 20 déclarants · $102.7M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 0 (0 vs T. préc.) | 1 (-323 vs T. préc.) | 0 (0 vs T. préc.) | 1 (0 vs T. préc.) | -8K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| KRYGER CAPITAL Ltd | $75 398 932 | 1 045 320 | 73,42% | Actions |
| VANGUARD GROUP INC | $6 863 530 | 95 155 | 6,68% | Actions |
| EFG Asset Management (North America) Corp. | $6 499 913 | 149 149 | 6,33% | Actions |
| AXA Investment Managers S.A. | $4 429 239 | 101 658 | 4,31% | Actions |
| ANGELO GORDON & CO., L.P. | $3 245 850 | 45 000 | 3,16% | Actions |
| Toroso Investments, LLC | $2 628 417 | 36 440 | 2,56% | Actions |
| WOLVERINE TRADING, LLC | $1 023 120 | 24 000 | 1,00% | Option d'achat |
| Orion Portfolio Solutions, LLC | $675 595 | 22 886 | 0,66% | Actions |
| CIBC WORLD MARKETS CORP | $552 372 | 7 658 | 0,54% | Actions |
| WOLVERINE TRADING, LLC | $456 141 | 10 700 | 0,44% | Option de vente |
| Eisler Capital Management Ltd. | $322 088 | 7 600 | 0,31% | Option d'achat |
| WOLVERINE TRADING, LLC | $285 493 | 6 697 | 0,28% | Actions |
| Nuveen Asset Management, LLC | $167 268 | 5 752 | 0,16% | Actions |
| AlphaQuest LLC | $104 589 | 1 450 | 0,10% | Actions |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | $19 572 | 663 | 0,02% | Actions |
| Lindbrook Capital, LLC | $16 708 | 566 | 0,02% | Actions |
| COMERICA BANK | $10 956 | 152 | 0,01% | Actions |
| Byrne Asset Management LLC | $1 372 | 102 | 0,00% | Actions |
| FTB Advisors, Inc. | $511 | 18 | 0,00% | Actions |
| Hemington Wealth Management | $0 | 7 | 0,00% | Actions |
Initiés de la société 20 initiés · 11 dirigeants · 9 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Sarah Boyce | President and CEO | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Michael F Maclean | Chief Financial Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Joseph Baroldi | Chief Operating Officer | 2 février 2021 A | — | 0 | 0 | $0 |
| Charles Calderaro III | Chief Technical Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Kathleen P. Gallagher | Chief Program Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Teresa Mccarthy | Chief Human Resources Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Michael W. Flanagan | Chief Scientific Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Steven George Hughes | Chief Medical Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Eric Mosbrooker | Chief Commercial Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| John B Moriarty | Chief Legal Officer | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Jae B. Kim | Chief Medical Officer | 2 février 2021 A | — | 0 | 0 | $0 |
| Simona Skerjanec | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Jean Jinsun Kim | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Tamar Thompson | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Noreen Henig | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Troy Edward Wilson | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Edward M. Kaye MD | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Carsten Boess | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| LEVIN ARTHUR A | Administrateur | 27 février 2026 D | 0 | 0 | 0 | $0 |
| Roderick Wong, M.D. | — | 16 juin 2021 A | — | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| RTW Investments, LP, Roderick Wong ×6 dépôts | 29 octobre 2025 | 3,10% | Amendement | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 15 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 15 juillet 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| IWV · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWN · iShares Trust | — | — | 17 août 2026 | Quotidien |
| IWO · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWM · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWC · iShares Trust | — | — | 18 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 17 août 2026 | Quotidien |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 juillet 2026 | Quotidien |
| ESGV · VANGUARD WORLD FUND | — | — | 30 juillet 2026 | Quotidien |